{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T12:04:11Z","timestamp":1789301051373,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,13]]},"DOI":"10.7759\/cureus.116170","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:25:36Z","timestamp":1789298736000},"source":"Crossref","is-referenced-by-count":0,"title":["A Family With Discordant Germline BRCA1 and BRCA2 Variants: A BRCA1-Positive Mother and BRCA2-Positive Daughter With Possible Paternal Inheritance"],"prefix":"10.7759","author":[{"given":"Masahiro","family":"Kanamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroharu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer","author":"Petrucelli N","year":"2026","unstructured":"Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. GeneReviews\u00ae [Internet]. Adam MP, Bick S, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2026."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker KB","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al.. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017, 317:2402-16. 10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline","volume":"42","author":"Bedrosian I","year":"2024","unstructured":"Bedrosian I, Somerfield MR, Achatz MI, et al.. Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline. J Clin Oncol. 2024, 42:584-604. 10.1200\/JCO.23.02225","journal-title":"J Clin Oncol"},{"key":"ref4","unstructured":"National Comprehensive Cancer Network. genetic\/familial high-risk assessment: breast, ovarian, pancreatic, and prostate. (2026). Accessed: July 14, 2026: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1545."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2021.11.003","article-title":"Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer","volume":"260-1","author":"Mampel A","year":"2022","unstructured":"Mampel A, Sottile ML, Denita-Ju\u00e1rez SP, Vargas AL, Vargas-Roig LM. Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer. Cancer Genet. 2022, 260-1:14-17. 10.1016\/j.cancergen.2021.11.003","journal-title":"Cancer Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2013-0263","article-title":"Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family","volume":"51","author":"Vietri MT","year":"2013","unstructured":"Vietri MT, Molinari AM, Caliendo G, et al.. Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family. Clin Chem Lab Med. 2013, 51:2319-24. 10.1515\/cclm-2013-0263","journal-title":"Clin Chem Lab Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911499","article-title":"Increased co-occurrence of pathogenic variants in hereditary breast and ovarian cancer and Lynch syndromes: a consequence of multigene panel genetic testing?","volume":"23","author":"Infante M","year":"2022","unstructured":"Infante M, Arranz-Ledo M, Lastra E, et al.. Increased co-occurrence of pathogenic variants in hereditary breast and ovarian cancer and Lynch syndromes: a consequence of multigene panel genetic testing?. Int J Mol Sci. 2022, 23:11499. 10.3390\/ijms231911499","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05931-3","article-title":"Feasibility of targeted cascade genetic testing in the family members of\u00a0BRCA1\/2 gene\u00a0pathogenic variant\/likely pathogenic variant carriers","volume":"12","author":"Lee J","year":"2022","unstructured":"Lee J, Ham JY, Park HY, et al.. Feasibility of targeted cascade genetic testing in the family members of\u00a0BRCA1\/2 gene\u00a0pathogenic variant\/likely pathogenic variant carriers. Sci Rep. 2022, 12:1842. 10.1038\/s41598-022-05931-3","journal-title":"Sci Rep"},{"key":"ref9","unstructured":"U.S. Food and Drug Administration. myChoice CDx technical information (P190014\/S003). (2026). Accessed: July 14, 2026: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/P190014S003C.pdf."},{"key":"ref10","unstructured":"Ministry of Health, Labour and Welfare, Japan. matters related to the medical fee schedule (medical services), attachment to Health Insurance Bureau Medical Division Notification No. 0305-6 [PDF in Japanese]. (2026). Accessed: August 9, 2026: https:\/\/www.mhlw.go.jp\/content\/12400000\/001732089.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522393-a-family-with-discordant-germline-brca1-and-brca2-variants-a-brca1-positive-mother-and-brca2-positive-daughter-with-possible-paternal-inheritance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:25:38Z","timestamp":1789298738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522393-a-family-with-discordant-germline-brca1-and-brca2-variants-a-brca1-positive-mother-and-brca2-positive-daughter-with-possible-paternal-inheritance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,13]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.116170","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,13]]}}}